                             NBER WORKING PAPER SERIES




             TECHNOLOGICAL PROGRESS AND HEALTH CONVERGENCE:
                  THE CASE OF PENICILLIN IN POST-WAR ITALY

                                        Marcella Alsan
                                       Vincenzo Atella
                                       Jay Bhattacharya
                                        Valentina Conti
                                     IvÃ¡n MejÃ­a-Guevara
                                         Grant Miller

                                     Working Paper 25541
                             http://www.nber.org/papers/w25541


                    NATIONAL BUREAU OF ECONOMIC RESEARCH
                             1050 Massachusetts Avenue
                               Cambridge, MA 02138
                                   February 2019




We would like to thank Giovanni Vecchi for useful discussion and comments during the early
stage of this research project. Alsan gratefully acknowledges support from the Eunice Kennedy
Shriver National Institute of Child Health and Human Development (NICHD) 5K01-HD084709.
Bhattacharya thanks the National Institute on Aging (NIA) for support for this work through the
Stanford Center for Demography and Economics of Health and Aging (5P30AG017253). Lena
Schoemaker, Afia Khan, Anlu Xing and Morgan Foy provided excellent research assistance. The
views expressed herein are those of the authors and do not necessarily reflect the views of the
National Bureau of Economic Research.

NBER working papers are circulated for discussion and comment purposes. They have not been
peer-reviewed or been subject to the review by the NBER Board of Directors that accompanies
official NBER publications.

Â© 2019 by Marcella Alsan, Vincenzo Atella, Jay Bhattacharya, Valentina Conti, IvÃ¡n MejÃ­a-
Guevara, and Grant Miller. All rights reserved. Short sections of text, not to exceed two
paragraphs, may be quoted without explicit permission provided that full credit, including Â©
notice, is given to the source.
Technological Progress and Health Convergence: The Case of Penicillin in Post-War Italy
Marcella Alsan, Vincenzo Atella, Jay Bhattacharya, Valentina Conti, IvÃ¡n MejÃ­a-Guevara,
and Grant Miller
NBER Working Paper No. 25541
February 2019
JEL No. I10,J10,N00

                                          ABSTRACT

Throughout history, technological progress has transformed population health, but the
distributional effects of these gains are unclear. New substitutes for older, more expensive health
technologies can produce convergence in population health outcomes, but may also be prone to
â€œelite captureâ€ leading to divergence. This paper studies the case of penicillin using detailed
mortality statistics and exploiting its sharply-timed introduction in Italy after World War II. We
find penicillin reduced both the mean and standard deviation of infectious diseases mortality,
leading to substantial convergence across disparate regions of Italy. Our results do not appear to
be confounded by competing risks or mortality patterns associated with World War II.


Marcella Alsan                                   Valentina Conti
Stanford Medical School                          Food and Agriculture Organization of
Center for Health Policy/PCOR                    the United Nations
117 Encina Commons, Room 218                     Viale delle Terme di Caracalla
Stanford, CA 94304                               Rome 00153
and NBER                                         Italy
malsan@stanford.edu                              valentinaconti23@yahoo.it

Vincenzo Atella                                  IvÃ¡n MejÃ­a-Guevara
University of Rome Tor Vergata                   Center for Population Health Sciences
atella@uniroma2.it                               Stanford University
                                                 Stanford, CA 94305
Jay Bhattacharya                                 imejia@stanford.edu
117 Encina Commons
CHP/PCOR                                         Grant Miller
Stanford University                              CHP/PCOR
Stanford, CA 94305-6019                          Stanford University
and NBER                                         117 Encina Commons
jay@stanford.edu                                 Stanford, CA 94305-6019
                                                 and NBER
                                                 ngmiller@stanford.edu
I       Introduction

Technological progress in medicine has been described as a leading explanation for the in-
crease in post-World War II era (Davis 1956; Preston 1975; Easterlin 1999; Mokyr 2002;
Acemoglu and Johnson 2007) and is often put forth as a solution to health challenges in
developing countries. Yet technological progress can also have unintended consequences for
the distribution of disease. If only elites can afford a health technology, or if a technology is
a private good that might substitute for public good provision, such innovation could widen
health disparities, at least initially (Mosca 1939; Olson 1965; Kremer and Willis 2016; Ashraf
et al. 2016). Alternatively, â€œbreakthroughâ€ health technologies that are less expensive may
supplant older, more expensive ones may encourage population health convergence.
        In this paper, we analyze the effects of the introduction of penicillin, arguably one of
the most important medical technologies of the twentieth century (Tomes 1990, 1998). Dis-
covered to kill Staphylococcus bacteria by Alexander Fleming in 1928 â€“ and successfully
isolated and produced by Howard Florey, Ernst Chain, and Norman Heatley in 1939 â€“
this new â€œmiracle drugâ€ quickly became the first-line treatment for pneumonia, diphtheria,
syphilis, gonorrhea, scarlet fever, and other infectious diseases (Dowling 1977; Levy 1992).1
Penicillinâ€™s achievements were preceded by those of sulfa agents, the first chemotherapy de-
veloped to fight infection and the subject of scholarship by Jayachandran, Lleras-Muney
and Smith (2010), who find the introduction of sulfa drugs led to impressive reductions in
maternal mortality and pneumonia deaths in the historical United States.2
        We build off the Jayachandran et al. (2010) study in two ways: first, by exploring the
role penicillin had on average mortality in Italy following its introduction by the United
    1
      The Lancet published a high-profile article in 1943 entitled â€œGeneral and Local Administration of Peni-
cillin,â€ describing the effectiveness of penicillin in treating wounded soldiers in North Africa (Florey and
Florey 1943). Some scholars estimate that penicillin saved at least 300,000 lives during the Second World
War (Dowling 1977; Levy 1992; Ratcliff 1945).
    2
      Conybeare (1948), Loudon (1988), and Mackenbach and Looman (1998) also provide suggestive evidence
on the importance of antibiotics. By contrast, some studies suggest that penicillin did not have the dramatic
effect commonly attributed to it (Hemminki and Paakkulainen (1976) studying Finland and Sweden, for
example).



                                                     1
Nations in the aftermath of World War II, and second, and more generally, by documenting
the effects of the technology on the distribution of mortality.3 Some scholars suggest that the
distribution of new technologies, even inexpensive ones, often benefit the elite first (Brenzel
and Claquin 1994). Others suggest that more portable technologies which do not require
large scale infrastructure investments are less prone to elite capture and have considerable
potential to improve population health (Acemoglu and Robinson 2008; Mosca 1939; Olson
1965). For penicillin, this could be particularly true given that political decision-making
often targeted expensive water and sanitation infrastructure â€“ which can greatly reduce the
spread of infectious diseases â€“ towards more elite neighborhoods and communities (Bigatti
2014; Massarutto 2011; Picci 2002; Troesken 2004). Finally, technological progress may
be â€œnecessaryâ€ but not â€œsufficientâ€ for health convergence â€“ institutions may be critical to
ensure benefits are distributed to those most in need.
    To study the distributional consequences of the introduction of penicillin, we assemble a
dataset of Italian vital records spanning much of the twentieth century (Atella, Francisci and
Vecchi, 2017). We use these data to estimate the contribution of penicillin to infectious dis-
ease mortality decline in Italy during the twentieth century. Focusing on the years between
1924 and 1955, we first establish its average effect on mortality by interacting the sharp tim-
ing of penicillin introduction with causes of death sensitive to penicillin, controlling for time-
and region-level effects as well as regional linear time trends. We then estimate penicillinâ€™s
effect on the distribution of mortality in four ways: first, by analyzing changes in the age
distribution of deaths over time, using Kolmogorov-Smirnov (KS) tests to detect significant
differences in these distributions year-by-year; second, using our econometric approach akin
to our framework for studying mean reductions in mortality rates, but testing for differential
declines by initial level of infectious disease death rates; third, testing for Î²-convergence,
following the literature on macroeconomic growth and economic convergence (Barro and
Sala-i-Martin 1992); and, fourth, testing for Ïƒ-convergence by estimating the relationship
  3
    Sulfa drugs are distinct from beta-lactam antibiotics, of which penicillin is the first developed (Mandell,
Douglas and Bennett 2010).


                                                      2
between penicillin introduction and changes in the standard deviation of regional mortality
rates (Janssen et al. 2016).
   We find sharply-timed reductions in penicillin-sensitive mortality rates across Italy that
closely coincide with the introduction of penicillin in 1947. There are no trend differences
between penicillin-sensitive and penicillin-insensitive diseases prior to 1947, and the subse-
quent decline of about 0.3 deaths per thousand annually represents a 66% reduction relative
to the average rate of penicillin-sensitive deaths in earlier years. Then, using all four esti-
mation approaches, we find clear evidence of mortality rate convergence across regions of
Italy. Relative to years prior to 1947, the introduction of penicillin reduced the disper-
sion of penicillin-sensitive mortality rates across regions by 68%, explaining 40% of all-cause
convergence over this period.
   We also consider two important threats to the internal validity of our analyses. The
first is competing risks. Because our estimation framework relies on comparisons between
penicillin-sensitive and penicillin-insensitive diseases, reductions in penicillin-sensitive deaths
could mechanically increase non-communicable disease (NCD) mortality as those benefitting
from penicillin live long enough to suffer and die from non-infectious causes. We show that
competing risks are not a threat in practice because the decline in penicillin sensitive death
rates is present when examining a simple change over time (i.e. not making comparisons with
NCDs). Furthermore, even when the sample time frame is limited to a very short window
following pencillinâ€™s debut, thereby reducing the movement of infectious disease survivors
into deaths due to non-infectious causes, we still find statistically significant and medically
meaningful effects. The second issue is that penicillin was introduced shortly after the end of
World War II. Infectious disease mortality rates commonly surge during wartime (Erdem et
al. 2011; Zapor and Moran 2005), so their decline relative to non-infectious mortality rates
could partly reflect the end of conflict and regression to the mean. However, our results
are similar across areas with varying degrees of war-related destruction and are robust to
excluding years 1943â€“1945 (the years of most intense conflict in Italy) from our estimation.


                                                3
         The paper proceeds as follows. Section II provides historical background on public health
in Italy and the introduction of penicillin, and Section III describes the construction of the
dataset. Section IV focuses on the role of penicillin for mean reductions in mortality, and
examines penicillinâ€™s contributions to population health convergence. Section V presents es-
timation results. Section VI considers competing risks and presents other robustness checks,
and Section VII concludes.

II        Background

II.A        Early Efforts to Combat Infectious Disease Mortality in Italy

At the time of unification in 1861, life expectancy at birth in Italy was approximately 29
years, and the crude death rate was about 35 per 1,000 people (Atella, Francisci and Vecchi,
2017). In 1887, Francesco Crispiâ€™s government introduced the countryâ€™s first sanitary reforms
under the Crispi-Pagliani law.4 However, infectious disease deaths in Italy did not begin to
decline until the early twentieth century, which historians link to improvements in municipal
hygiene under provisions of the law governing water quality and sanitation in urban areas
(Giovannini 1996; Giuntini 1999; Pogliano 1984). During fascist rule (1920-1943), public
health initiatives targeted the so-called â€œtriple endemic diseases:â€ malaria, syphilis, and
tuberculosis.5
         Italyâ€™s nascent healthcare system and reforms often failed to reach its poorest members
(Giovannini 1996; Giuntini 1999; Pogliano 1984).6 Municipal authorities were responsible
for providing healthcare to the indigent, yet in practice private charitable organizations
     4
      The establishment of a health system is interpreted by historians as one of the most important achieve-
ments of Italian â€œpolitical and moral lifeâ€ at the beginning of the new Kingdom [Croce (1928), cited in
Cosmacini (2005), p. 345].
    5
      The most important provisions focused on malaria were issued between 1923 and 1934 through a series
of laws designed to arrive at a thorough land reclamation operation (bonifica integrale). The Consolidation
Act on the reclamation of marshlands was approved with Royal Decree no. 3256 of 30 December 1923. Law
no. 3134 of 24 December 1928, called the â€œMussolini Law,â€ granted financial resources to land reclamation
and provided for integration regarding the supply of drinking water and the construction of rural buildings,
hamlets, and roads.
    6
      The lawâ€™s principles of universalism became effective only in 1978, when the Italian National Health
Service System (SSN) was established.




                                                     4
provided these services (Opere Pie, or â€œPious Organizationsâ€).7 A Royal Decree in 1884
established that private firms could invest in the water sector (Ermano and Massarutto
2012). Massarutto (2011) argues this decree and the ensuing privatization directed water
supply towards the wealthy in urban areas. As late as the 1950s, only 52% of private houses
in Italy received potable water (Doria 2010), and only 7% had all three utilities: potable
water, adequate sanitation, and electricity (Barra Bagnasco 1996).8
       Mortality rates in Italy declined on average during the early- to mid-1900s (see Figure
1), though wide regional health disparities in infectious disease mortality were prevalent at
the beginning of this period (Figure 2, Panel A). Nationally, life expectancy at birth in Italy
rose to 40-45 years â€“ but varied by as much as 12 years across regions.9 These regional
disparities peaked in 1925-1930, remained high until WWII, and then declined sharply at
the end of the war. Understanding whether the introduction of penicillin contributed to the
compression of regional mortality rates is a central focus of this paper.

II.B      The Advent of Penicillin in Italy

The supply of penicillin in Italy began in 1947 (Luzzi 2004). In its early stage of distribution
(1945 and 1946) penicillin was available in Italy through international aid only, imported by
the UNRRA (United Nations Relief and Rehabilitation Administration) channel and limited
in quantity. At that time the black market was flourishing. Therefore, having enough money
and connections, people could reach for the drug (the initial distribution of penicillin in Italy
by the US Army started with the main intent of using it to treat the spreading of venereal
   7
      The â€œnon-poorâ€ generally used services provided by individual private-practice doctors (medici libero-
esercenti ) who made home visits.
    8
      Until the end of WWII, national public spending for infrastructure was concentrated in the North. On
public investments in water, a Royal Decree issued in 1884 created a dualism in the management of water
services: water was public, but private companies could invest in the sector once awarded government licenses
(Ermano 2012). As a result, water was largely provided to wealthy families in urban areas (Massarutto
2011). Although many subsequent laws governing water management were issued between 1861 and 1950,
universalism in the water sector was not achieved until the late 1950s (Mantelli and Temporelli 2007).
Modern water infrastructure in poorer southern regions was completed only in the late 1980s (Mantelli and
Temporelli, 2007).
    9
      During the 1920s the regional variation in life expectancy at birth was almost as large as that estimated
for Indian states between 2011 and 2016 â€“ ranging from 61.5 years in Madhya Pradesh to 77 years in Kerala
(Ponnapalli et al., 2013).


                                                      5
diseases). To resolve this problem ENDIMEA (Ente Nazionale Distribuzione Medicinali
agli Alleati) was established, which began its work on October 1st, 1944. Since January
1st, 1945, each provincial health office began to communicate to the General Directorate
of Public Health (DGSP), within the Ministry of the Interior, estimates of the demand for
medicines for the quarter. The DGSP, based on the requests and the availability of drugs,
granted the drugs to the applicants, informing ENDIMEA to ship the product to the local
private wholesalers. Once the wholesaler collected the drugs, he was responsible for the
distribution of medicines to the Provincial Health Offices. The latter also had an obligation
to follow the drug during the journey from the wholesaler warehouse to the pharmacies or
hospitals, in order to prevent theft and illegal sales.10
       Italian patients could receive the new drug free of charge if requested by their physicians.
Provincial Health Offices were held accountable for any shortages of medicines, and phar-
macists received a high margin for the sale of antibiotics, which discouraged the emergence
of an underground market favoring the wealthy (Battini 1946; Luzzi 2004).

III      Data

III.A       Vital Statistics Data11

The Italian National Statistical Office (ISTAT) provides national vital statistics in annual
Health Statistics Yearbooks (Annuario di Statistiche Sanitarie) starting from 1887. Vital
statistics for years 1924-1955 were digitized at the region-year-cause of death level.12
       Harmonizing Regions. ISTAT data provides death counts for Italyâ€™s regions over time.
  10
      The Italian health authorities were responsible for any shortages of medicines. In the spring of 1945
the drug became available via physician prescription, but only in the City Public Health Offices (Ufficio
dâ€™Igiene). In 1947, the pharmaceutical company â€œSPA Milanâ€ became the first private Italian company to
market antibiotics, selling Supercillin (in vials) and Prontocillin (tablets). A year later, the Anglo-American
monopoly over penicillin was broken by Domenico Marotta, then-director of the Istituto Superiore di Sanit,
who called Ernst Chain to lead the International Centre for Microbiological Chemistry in Rome.
  11
     For a complete description of the vital statistics, see Appendix A.
  12
     To the best of our knowledge, formal demographic analyses of the quality and completeness of Italyâ€™s
historical mortality statistics have not been published. However, Italian vital statistics back to the nineteenth
century are included in the Human Mortality Database (HMD), and data quality is a central criterion for
HMD inclusion. http://www.mortality.org/. (Data documentation for Italy HMD available at: http:
//www.mortality.org/hmd/ITA/InputDB/ITAcom.pdf).



                                                       6
Due to changes in administrative regional borders over our period of investigation, we had
to aggregate some regions. From 1924 until the end of WWII, Italy was organized into
18 administrative regions with only minor changes across region borders. The only excep-
tion was the establishment of Valle dAosta in September 1945. For this reason, to obtain
a harmonized regional dataset from 1924 to 1954 we treat Piedmont and Valle dAosta as
a single region. Thus, our sample includes the following 18 regions: Piedmont and Valle
dâ€™Aosta, Lombardy, Trentino Alto Adige, Veneto, Friuli Venezia Giulia, Liguria, Emilia Ro-
magna, Tuscany, Umbria, Marche, Lazio, Abruzzi and Molise, Campania, Apulia, Basilicata,
Calabria, Sicily and Sardinia.13
    Harmonizing Cause of Death. Officially, ISTAT assumed the responsibility of collecting
mortality data at individual level only in 1930, following Law no. 2238 issued in December
1929. Previously, the statistical office was within the Ministry of Agriculture, Industry and
Trade via Indagine sulle cause di morte. ISTAT collects this information using an official
reporting format (â€œScheda di morteâ€) following international standards recommended by the
World Health Organization (WHO). These individual death certificates consist of two parts.
A general practitioner or coroner certifies the first part and ascribes cause. The â€œinitial
causeâ€ â€“ disease or trauma â€“ is recorded, which may have led to additional complications
but initiated a causal chain leading to death. Diagnostic codes are then assigned to each
death using WHO International Classification of Diseases (ICD) criteria. The second part
is completed by a municipal civil registrar and includes information about the demographic
and social characteristics of the deceased.
    Causes of death reported in Italyâ€™s vital records change over time. We therefore use
categories that can be consistently identified and tracked across all study years, effectively
adopting the classification used in 1956â€“1957 for all years of our analysis (1924â€“1955).14 We
   13
      For sake of completeness, in December 1963 the region of Molise was established by splitting the â€œAbruzzi
and Moliseâ€ into two distinct regions. This last change brought Italy to have the current administrative
structure based on 20 regions.
   14
      The 17 causes of death are the following: infective and parasitic diseases; tumors; allergic and endocrine
glands diseases; blood and hematopoietic diseases; psychic and personality disorders; nervous system diseases;
circulatory system diseases; respiratory system diseases; digestive system diseases; genitourinary system dis-


                                                       7
then classify each of these causes that can be consistently tracked over time according to
whether or not it can be treated with penicillin. Ultimately, this process yields 79 penicillin-
insensitive, 15 penicillin-sensitive, and 15 unclassified diseases.15 In our analysis of cause-
specific mortality we exclude unclassified deaths.
    Constructing war related destruction indicator. We measure destruction related to World
War II using the number of military and civilian deaths directly related to war causes at the
regional level that occurred between 1940 and 1945 (ISTAT 1957).16
    Constructing Rates. Finally, using death counts by region, year, and cause, we construct
mortality rates using data on regional populations in Italy over time. Specifically, to create
population denominators, we use regional population counts from Italyâ€™s decennial popula-
tion censuses provided by ISTAT. For inter-censual years, population estimates accounting
for births and deaths provides estimates of this population construction process using several
sources of population data (Vecchi, 2017; see Appendix A for more details).17
eases; complications of pregnancy; skin and tissue diseases; bones and locomotive organs diseases; congenital
malformations; early childhood particular diseases; senility and pathologic states; accidents, traumatisms,
and poisonings. The coding system adopted during years 1924â€“1955 has changed from the International
Analytical Classification (IAC) to the ISTAT Intermediate Classification (IIC) adopted in subsequent years.
Moreover, from 1958 onwards, there is a higher disaggregation of diseases with respect to years 1956â€“1957,
due to the inclusion of new death-related causes.
   15
      The list of â€œpenicillin-sensitiveâ€ and â€œpenicillin-insensitiveâ€ categories of death are reported in Appendix
B.
   16
      The war victims are quantified according to the region of actual death, delivering a space/time quan-
tification of war conflicts. WWII severity indicator in Italy is provided by the official publication â€œMorti
e dispersi per cause belliche negli anni 1940â€“45â€ (The dead and the missing due to war causes between
1940â€“1945) (ISTAT, 1957). The intensity of war destruction was quantified based at the median. Regions
above-median conflict deaths are: Piedmont-Valle dâ€™Aosta, Veneto, Friuli Venezia Giulia, Emilia Romagna,
Toscana, Umbria, Marche, Lazio. Lombardy, Trentino Alto Adige, Abruzzi and Molise, Campania, Puglia,
Basilicata, Campania, Sicilia, Sardegna. See Atella, Di Porto, and Kopinska (2017) for a detailed description
of the data used. WWII-related death rates were then computed by dividing death county by the average
regional population between 1940â€“1945.
   17
      Population estimates were interpolated into age bins of 0â€“25, 26â€“30, 31â€“35, 36â€“40, 41â€“45, 46â€“50, 51â€“
55, 56â€“60, 61â€“65, 66â€“70, 71â€“75, and 76+ by using known population data for years 1921â€“1927, 1931â€“1936,
1943â€“1950, 1953, 1957, and 1959â€“1961. To estimate missing population data, we broke the age bins into
separate individual age columns and assumed a uniform population distribution for each age within an age
bin. We interpolated missing age-specific population by taking the current yearâ€™s age-specific population
and adding the previous yearâ€™s age-specific mortality to get the previous yearâ€™s age-specific population. We
use the same methodology in the opposite direction by interpolating the age-specific population data of
the subsequent year by taking the current yearâ€™s age-specific population and subtracting the current yearâ€™s
population age-specific mortality. Afterwards, we re-aggregated the age columns into the original age bins
for the population controls of our study.



                                                        8
       Our final sample contains region-year-cause of death observations for years 1924â€“1959.
Table 1 shows descriptive statistics on all-cause mortality for penicillin-sensitive and penicillin-
insensitive diseases before and after penicillin introduction.

III.B      Human Mortality Database (HMD) Data

We also use national-level data on age-specific deaths from the Human Mortality Database
(HMD) in two ways (HMD 2017).18 First, because the regional vital statistics do not contain
information about deaths by age, precluding age-adjustment, we control for age-specific
population counts.19 Second, we directly examine changes in the age distribution of deaths
over time as an alternative strategy for studying mortality convergence.

III.C      Graphical Analysis

Mortality Decline by Cause. As Figure 1 shows, Italyâ€™s total mortality rate fell substantially
between 1924 and 1955. However, this decline varied dramatically by cause â€“ and in particu-
lar, by penicillin sensitivity. Panel A of Figure 2 shows that with the official introduction of
penicillin in 1947, the decline in regional mortality rates for penicillin-sensitive causes accel-
erated sharply. Moreover, the variance in regional death rates sensitive to penicillin became
markedly more compressed beginning in 1947, with substantial convergence occurring by
the mid-1950s. Panel B of Figure 2 demonstrates regional mortality rates for non-infectious
causes did not decline over the entire period â€“ nor did their variance.20
  18
     National-level HMD estimates are constructed by HMD investigators using vital statistics, population
censuses, and population estimates directly from ISTAT and from other researchers working on behalf of
ISTAT. Death counts in the Italian vital statistics are based on the de facto population (â€œpopolazione pre-
senteâ€) until 1980 and on the de jure population (â€œpopolazione residenteâ€) afterwards. Therefore, mortality
rates before 1981 in the HMD are based on population estimates of the de facto population, calculated from
census counts to consider this change in the coverage of vital statistics (Glei 2015). Death counts from the
vital statistics are also adjusted both to include missing military deaths during World Wars I and II and
to spatially redistribute deaths by age and calendar year (Jdanov et al. 2008). For the period 1937â€“51,
intercensal survival methods are used to derive population estimates using pre- and post-war census counts
(Jdanov et al. 2008).
  19
     This data is also available online at:http://www.mortality.org/
  20
     More work is required to address concerns about the confounding role of World War II given that
infectious disease deaths often exceed direct casualties due to conflict (Erdem et al. 2011; Zapor and Moran
2005). We address this issue later in Section VI.B. Further, one might also argue that WWII has favored
internal migration flows from poorer to richer regions, thus contributing to higher differentials among regional
mortality rates. Atella, Deb and Kopinska (2019) show that the phenomenon of migration within Italian


                                                       9
    Mortality Decline by Age. Figure 3 depicts the age distribution of period life table deaths
in Italy for years between 1924 and 1955. The figure reveals substantial reductions in infant
and child mortality over time (which are generally due to infectious causes, mostly penicillin-
sensitive (Vercelli et al. 2014)). As a result, deaths appear to become more concentrated at
older ages â€“ a pattern consistent with convergence, although the timing of this compression
is less readily evident (Section VI investigates this issue more closely).
    Standard Deviation and Average Life Expectancy: Figure 4 shows both life expectancy
at birth and the standard deviation of age at death across regions (a common indicator
used in the literature to measure mortality convergence and lifespan inequality (Edwards
and Tuljapurkar 2005; Gillespie et al. 2014)) by year. Life expectancy at birth increases
from 51.5 in 1924 to 57.6 in 1939, declines abruptly during WWII until the 1943 Italian
armistice, recovers quickly to its pre-war level, and continues to increase in the post-war
years. The standard deviation of age at death declines little during the pre-war period (as
life expectancy at birth is rising), remains relatively constant during WWII, and then declines
precipitously beginning in the late 1940s (around the time that penicillin was introduced)
and throughout the post-war period. This rapid decline beginning in the latter 1940s is
suggestive of mortality convergence.
    Standard Deviation by Cause: Figure 5 shows the standard deviation of regional death
rates separately for the all-cause mortality rates, penicillin-sensitive mortality rates, and
penicillin-insensitive mortality rates over time. Before WWII, the standard deviation tra-
jectories of penicillin-sensitive and -insensitive mortality rates were similar. Both experience
disruptions during the war period, but after 1947 the standard deviation of penicillin-sensitive
mortality rates across regions converges, while the standard deviation of penicillin-insensitive
mortality rate slightly diverges.
regions began in earnest in 1951.




                                              10
IV       Estimation

IV.A       Mortality Decline

Building on graphical evidence shown in Figures 2 and 4, our empirical strategy tests for
sharply-timed differential trend breaks in penicillin-sensitive mortality rates (relative to
penicillin-insensitive mortality rates) coincident with the introduction of penicillin in 1947.
Specifically, we estimate:


(1)            mict = Î± + Î³i + Î´t + Î¸c + Î²(Itpost âˆ— Sensitivec ) + Xit Ï• + Î³i âˆ— t + ict ,


for regions i, causes of death c, and years t. mict is a region-cause-year specific death rate
(specified both in level and natural log form). Itpost is a dummy variable equal to one for
observations in years 1947 or later, Sensitive is a dummy variable for whether or not cause
c is sensitive to penicillin, and X is a vector of covariates including interpolated population
estimates in discrete age categories. We include year, region, and disease fixed effects, and
our preferred specification also includes linear time trends interacted with region dummies.
Standard errors are clustered by region, and we report p-values corresponding to block
bootstrapped standard errors.21
       We also assess the temporal dynamics of the introduction of penicillin by substituting a
vector of year dummy variables for , Itpost in Equation (1):


                                                 Ïj (Sensitivec âˆ— Itj ) + Xit Ï• + Î³i âˆ— t + ict ,
                                           X
(2)           mict = Î± + Î³i + Î´t + Î¸c +
                                             j



where Itj is a vector of j year dummy variables and all other variables are defined as before.
  21
    To assess the robustness of our results, we also estimate variants of specification (1), using both levels
and log specifications and including region-specific linear time trends.




                                                      11
IV.B       Mortality Convergence

To study mortality convergence at the national level, we first analyze changes in the distri-
bution of age at death (Kannisto 2000; Fries 1980; Wilmoth and Horiuchi 1999). Specifically,
we use Kolmogorov-Smirnov (K-S) tests to formally assess if the timing of statistically signif-
icant changes in the distribution of age at death coincides with the introduction of penicillin
in 1947, comparing the distribution in each year between 1924-1954 with the last year in our
sample, 1955.22
       Second, we test for mortality convergence associated with the introduction of penicillin
using an econometric framework similar to the one that we use for estimating mean reductions
in penicillin-sensitive mortality rates. Specifically, we re-estimate Equation (1), stratifying
by the pre-1947 level of both penicillin-sensitive mortality rates and overall regional mortality
rates.
       Third, we test for Î²-convergence, or convergence in levels of mortality rates, following
the approach of Barro and Sala-i-Martin (1992) to study convergence in Gross Domestic
Product (GDP) per capita across countries. This approach assesses if regions with higher
pre-1947 penicillin-sensitive and -insensitive mortality rates converged towards regions with
lower mortality rates by sub-periods (before and after the introduction of penicillin, 1929-
1946 and 1947-1955). Specifically, we estimate:

                               (mict âˆ’ mict0 )
(3)                                            = Î± + Î³i + Î²mict0 + it
                                 (t âˆ’ t0 )

where mict is the mortality rate in region i due to cause c in initial year t0 (t0 = 1924 for the
first sub-period, and t0 = 1947 for the second sub-period) and Î² is the parameter of interest.
       Finally, we test for Ïƒ-convergence, or convergence in the standard deviation of mortality
  22
    A two-sample Kolmogorov-Smirnov statistic is used to test whether two empirical one-dimensional
distribution functions (Fm (x), Gn (x)) differ from each other. The KS statistic is defined by the formula
Dmn = supx | Fm (x) âˆ’ Gn (x) |. The null hypothesis that the q two samples come fromqthe same distribution
                                                               m+n
is rejected, at the level of significance Î±, when Dmn > c(Î±)   mn ,   where c(Î±) =    âˆ’ 12 ln( Î±2 ) (Stephens,
1974).


                                                   12
rates, across regions of Italy by re-estimating Equation (1) using the standard deviation
of cause-specific mortality rates by region as the dependent variable (Janssen et al. 2016;
Young et al. 2008).

V       Results

V.A       Mortality Decline

Table 2 reports results obtained by estimating Equation (1). Conditioning on year, region,
and disease fixed effects as well as the regional age distribution, mortality rates among
diseases sensitive to penicillin relative to those insensitive fell by approximately 0.3 per
thousand (and is statistically distinguishable from zero, p < 0.01) with the introduction
of penicillin. Relative to the mean mortality rate among deaths due to these causes prior
to 1947 (0.469, see Table 1), this represents a reduction of 58%.23 Column 2 adds region-
specific linear time trends. In both cases, the estimate of Î² is robust, with the mortality
rate decline associated with the introduction of penicillin remaining at about 0.3 per 1,000.
Columns 3 and 4 repeat this estimation for log mortality, showing robust reductions in
penicillin-sensitive mortality rates.
       Figure 6 then examines the dynamic pattern of mortality decline associated with penicillin
introduction in Italy, showing estimates and 95% confidence intervals for each year-specific
Ïj in Equation (2). Prior to the introduction of penicillin, there is little evidence of pre-
existing declines in penicillin sensitive mortality rates (relative to insensitive ones). Year-
specific estimates drop with the introduction of penicillin in 1947 and become negative and
statistically different from zero by 1948 (and in all subsequent years) with the diffusion of
penicillin. By the end of our study period in 1955, these year-specific estimates approach a
decline of 2.8 per 1,000 deaths.
  23
    To estimate this effect we divide the post-1947 mean average reduction in the cause-specific mortality
(regression coefficient in the first column of Table 2: -0.272), by the mean mortality rate for penicillin-sensitive
causes in the baseline period, between 1924â€“1946.




                                                        13
V.B    Mortality Convergence

Figure 7 first shows year-by-year K-S p-values for tests of differences between each yearâ€™s
distribution of age at death against the distribution in 1955 (the last year in our sample).
These p-values remain constant at nearly 0 for all years prior to the introduction of an-
tibiotics, indicating strongly significant differences from 1955 â€“ and then beginning in 1947,
these p-values rapidly rise to 1 (indicating no difference from 1955). This sharply-timed
compression in Italyâ€™s age distribution of deaths is highly consistent with the introduction
of antibiotics leading to convergence in mortality rates.
   Table 3 reports estimates obtained from Equation (1), stratified by level of penicillin-
sensitive mortality rates prior to 1947 (above and below the median). The first and second
columns show that after 1947, penicillin-sensitive mortality rates declined more in regions
with higher (above median) initial rates (by 0.29 per 1,000) than in those with lower (below
median) initial rates (0.26 per 1,000) â€“ and significantly so. Compared to the mean of the
pre-1947 penicillin-sensitive cause-specific mortality, these changes represent reductions of
61% and 55%, respectively.
   Table 4 reports Î²-convergence estimates from Equation (3).             Comparing penicillin-
sensitive mortality rates before vs. after the introduction of penicillin, the estimate of Î²
is almost four times greater after penicillin introduction (-0.075 vs. -0.021). Alternatively,
for penicillin-insensitive mortality rates, the estimate is not statistically significant prior to
1947 â€“ and is positive and statistically different from 0 afterwards, suggesting divergence in
penicillin-insensitive mortality rates.
   Finally, Table 5 (columns (1) and (2)) present estimates of sigma convergence by using the
standard deviation of deaths across regions and years for each of the two disease categories as
the dependent variable. We find that the standard deviation of penicillin-sensitive mortality
declines after penicillin is introduced (-0.113, p < 0.01) â€“ but not the standard deviation
of penicillin-insensitive mortality (-0.004). The results remain consistent after truncating
the sample in 1950 (row 2): the standard deviation of penicillin-sensitive mortality declines

                                               14
significantly (-0.089, p < 0.01), but not for penicillin-insensitive mortality (-0.009).24

VI       Identification and Threats to Validity

In this section, we discuss two potential treats to our interpretation of the effects of the
introduction of antibiotics on infectious disease mortality. In Section VI.A, we consider the
problem of competing risks â€“ specifically, the survival benefit of antibiotics increased the
exposure of the population to death from non-infectious causes. In Section VI.B, we discuss
how the chaotic end to World War II may have affected infectious disease mortality in Italy
during our sample period.

VI.A       Competing Risks

In our context, the competing risks problem concerns a possible increase in non-communicable
disease (NCD) mortality resulting from fewer people dying from infectious disease mortality
as a result of the introduction of penicillin. This phenomenon can influence our estimates
given that we compare penicillin-sensitive vs. penicillin-insensitive death rates over time
(Tsiatis, 1975; Peterson, 1976; HonoreÌ€ and Lleras-Muney 2006). In this section we study the
influence that competing risks has on our estimation of the contribution of penicillin to the
mortality decline in Italy.25 We present a simple framework for defining the particular com-
peting risk problem inherent in our main estimating equation, and describe an alternative
approach to bound the estimates.
       Period 0: In any period, deaths can be divided into mortality from two etiologies E =
{I, N C} where I indicates infectious diseases and N C reflects non-communicable diseases.


(4)                                             D = I + NC
  24
      We use a truncated sample to test the potential treat of competing risks in the interpretation of the
effects of the introduction of penicillin on infectious disease mortality, including our interpretation of sigma
convergence â€“ see Section VI.A.
   25
      Technically, if competing risks is a problem, it amounts to a violation of the Stable Unit Treatment Value
Assumption (SUTVA), which is necessary for unbiased estimates in a difference-in-difference framework such
as ours.




                                                      15
note that deaths from etiology E can be expressed as the mortality rate from E multiplied
by the number of susceptible from that etiology at time t: E = Âµe,t âˆ— S E,t . We assume that
mortality rate from non-communicable disease is exogenous to penicillin and, after period 0,
there are N 0 persons surviving in this closed population without births or migration.

Period 1: At the beginning of period 1, penicillin, p, is introduced which immediately treats
and cures those afflicted with infectious diseases, leading to a direct decline in mortality
associated with diseases of infectious etiology:


(5)                                      D1 = S I,1 ÂµI,1 (p) + S N C,1 ÂµN C


Period 2: By period 2, there are now indirect effects of penicillin, since those weaker
individuals that otherwise would have died from infectious disease are now alive (e.g. the
harvesting effect of infections has been reduced). These spared lives increase the size of the
susceptible non-communicable disease population:


(6)                                S N C,2 = N 0 âˆ’ S I,1 ÂµI,1 (p) âˆ’ S N C,1 ÂµN C .


                    âˆ‚ÂµI,i                                                            âˆ‚S N C,2
      Recall that    âˆ‚p
                            < 0 by the pharmacology of penicillin and                  âˆ‚p
                                                                                                > 0 by equation 6.
Hence the total effect of penicillin over time reflects both the direct effect on infectious deaths
and its indirect effect on non-communicable susceptibles.
      Our difference-in-differences estimate compares the changes in infectious and non-communicable
diseases related deaths, before vs. after the introduction of penicillin:26

                                                                                             
(7)                         S I,2 ÂµI,2 (p) âˆ’ S I,0 ÂµI,0 âˆ’ S N C,2 (p)ÂµN C âˆ’ S N C,0 ÂµN C


Given that the first term is negative (by the direct effects of penicillin) and the second, in
   26
      Equation 7 is normalized by total population in our empirical framework. Note there is also a positive
effect on susceptibles for infectious diseases at the beginning of period 2, but we ignore that detail since
it is dwarfed by the first order effect of penicillin which is to reduce the mortality associated with many
communicable causes.


                                                         16
the absence of an overall secular decline in mortality, is positive (by the indirect effects of
penicillin), our estimates are biased away from the null.27 Yet in our setting, there may
be a very prominent secular decline in mortality for all causes â€“ which is why a difference-
in-differences framework is preferred. Thus, estimates from both the simple and double
differences are biased, the former by a secular decline and mis-attribution of penicillin to
secular patterns, and the latter by competing risks.
       To gauge the relative importance of these two sources of bias, we zoom in on the pe-
riod very soon after penicillin was introduced (i.e. Period 1), so that our difference-in-
differences estimator is not influenced by competing risks (i.e. there is no indirect effects on
                                                                                           
non-communicable disease):             S I,1 ÂµI,1 (p) âˆ’ S I,0 ÂµI,0 âˆ’ S N C,1 ÂµN C âˆ’ S N C,0 ÂµN C . Shortly af-
ter penicillin is introduced, we are more likely to isolate the direct effect of penicillin on the
infectious disease mortality as the harvesting and death for more chronic, non-communicable
entities would not have not had time to occur. Specifically, we estimate the effect of peni-
cillin on sensitive (i.e. infectious) and insensitive (i.e. non-communicable) causes in a pre
vs. post framework and using the full vs. a truncated time period.
       These results are gathered in Table 5. For the truncated sample, ending in the year 1950
â€“ three years following the introduction of penicillin into Italy â€“ the results demonstrate that
both sensitive and insensitive mortality decline (row (2) columns (3) and (4)) though the
effect is much larger for the former. The estimates point to an important secular decline
in mortality, independent of penicillin, hence the negative post coefficient in column (4).
The difference-in-differences estimate ((âˆ’0.486) âˆ’ (âˆ’.0363)) is about âˆ’0.12, smaller than
the main estimates in Table 2 and a lower bound on penicillinâ€™s effects.
       Using the full sample, with an end year of 1955, the effect of penicillin introduction on
insensitive causes is more positive, reflecting the competing risk issue. Yet the magnitude
of this change is slight and statistically indistinguishable from the estimates using the 1950
cutoff. Moreover, the fact that the difference-in-differences point estimates are increasing
  27
    In the presence of a secular decline, the second term will be less negative than in the counterfactual of
absent an indirect effect of penicillin.


                                                       17
over time as per our event study is attributable to the first term in equation 7: the direct
effect of penicillin on infectious disease mortality (see row (3)). As discussed above, this
likely reflects the technologyâ€™s diffusion. When turning to sigma convergence, there is no
major concern for competing risks in any specification: convergence is limited to infectious
causes.
       In summary, the framework and results presented in this subsection show that the com-
peting risks problem in our context is small, given that a longer time window does not greatly
bias the second term in equation 7 in a positive direction. On the other hand, controlling for
a secular decline in mortality â€“ which is what differencing out of non-communicable causes
affords â€“ is important for obtaining less biased estimates.

VI.B        The End of World War II

Another potential concern with our results is the influence of the end of World War II on
infectious disease rates. Because infectious disease mortality rates commonly surge during
wartime (Erdem et al. 2011; Zapor and Moran 2005), their decline relative to non-infectious
mortality rates could partly reflect the end of conflict. Figure 2 (Panel A) provides at least
some prima facie evidence that this is not an important concern in our case â€“ mortality rates
sensitive to penicillin are declining until 1930, generally remain stable through 1945 (rather
than rising), and then resume their decline. However, we probe this issue further in two
ways.
       First, we test for differential penicillin effects in areas with varying degrees of war-related
destruction. Specifically, we re-estimate Equation (1) separately for regions with above-
and below-median degrees of war intensity, measured using conflict-related mortality rates
between 1940 and 1945.28 Columns 3 and 4 of Table 3 report estimates separately for regions
with higher and lower intensity of exposure to WWII. In general, the penicillin effect is larger
in areas with lower war intensity (0.29 per 1,000) relative to those with higher war intensity
  28
    This data is available in â€œMorti e dispersi per cause belliche negli anni 1940â€“45â€ (ISTAT, 1957) and is also
online at https:lipari.istat.it/digibib/causedimorte/IST3413mortiedispersipercausebellicheanni1940 45+OCRottimizz.pdf.



                                                   18
(0.26 per 1,000), and this difference is statistically significant.29
       Second, we simply exclude years 1943â€“1945 (the years of greatest conflict in Italy) from
our sample and again re-estimate Equation (1). Columns 5 and 6 of Table 3 show these
results â€“ the estimates are statistically equivalent to those that include these years.

VII       Conclusion

Although technological progress in health has produced dramatic gains in life expectancy
around the globe over the past century, it can also have unintended consequences for the dis-
tribution of disease. Health technologies that are inexpensive and substitute for older, more
expensive ones may lead to population health convergence, but they could also dispropor-
tionately benefit elites, widening health disparities. Notably, there has been little empirical
evidence to date on the consequences of major new health technologies for the distribution
of health in populations.
       Studying the seminal case of penicillin and focusing on Italy using newly digitized vital
statistics over several decades, we find that the introduction of penicillin not only reduced av-
erage infectious disease mortality rates dramatically (by 58%), but it also led to a substantial
reduction in the variance of mortality rates across Italian regions. Specifically, the standard
deviation in the age of death fell by nearly eight years after the introduction of penicillin
â€“ a decline of 27%. Our findings relate to the scholarship of researchers investigating post-
World War II health convergence across countries, such as Acemoglu and Johnson (2007)
and Deaton (2006), we find that the distribution of penicillin, at least in Italy, played an im-
portant role in such convergence and suggest an important role for point-of-care technologies
in reducing health inequalities.
  29
    We test for the significance of the difference between the coefficients obtained in the separate models by
pooling the samples used in both models, and specifying a triple interaction that includes an indicator for
high and low destruction. The coefficient for this interactions term was statistically significant (p-values <
0.01).




                                                     19
References
 [1] Acemoglu, Daron, and Simon Johnson. 2007. â€œDisease and Development: The Effect of
     Life Expectancy on Growth.â€ Journal of Political Economy 115: 925â€“985.
 [2] Acemoglu, Daron, and James A. Robinson. 2008. â€œPersistence of Power, Elites, and
     Institutions.â€ American Economic Review 98 (1): 267â€“93.
 [3] Ashraf, Nava, Edward L. Glaeser, and Giacomo A. M. Ponzetto. 2016. â€œInfrastructure,
     Incentives, and Institutions.â€ American Economic Review 106 (5): 77â€“82.
 [4] Atella, Vincenzo, Partha Deb, and Joanna A. Kopinska. 2019. â€œHeterogeneity in long-
     term health outcomes of Migrants within Italy.â€ Journal of Health Economics 63: 19â€“33.
 [5] Atella, Vincenzo, Edoardo Di Porto, and Joanna Kopinska. 2017. â€œStress, Famine and
     the Fetal Programming: The Long Term Effect of WWII in Italy.â€ CEIS Research Paper
     385.
 [6] Atella, Vincenzo, Silvia Francisci, and Giovanni Vecchi. 2017. â€œHealth.â€ In Measuring
     Wellbeing: A History of Italian Living Standards, edited by Giovanni Vecchi, Oxford
     University Press.
 [7] Barra Bagnasco, M. 1996. â€œHousing and Workshop Construction in the City.â€ In The
     Western Greeks, 353â€“60, edited by G. Pugliese Carratelli. Milan.
 [8] Battini, B. 1946. â€œServizio di distribuzione della penicillina, in ACISP, Notiziario
     dellâ€™Amministrazione Sanitaria 1944â€“1945.â€ Fascicolo unico, Roma, 226â€“32.
 [9] Barro, Robert J., and Xavier Sala-i-Martin. 1992. â€œConvergence.â€ The Journal of Po-
     litical Economy 100 (2): 223â€“51.
[10] Bigatti, Giorgio. 2014. â€œDa bere per tutti. Servizi idrici e politiche dellâ€™acqua in Italia
     tra Otto e Novecento. Uno sguardo di sintesi.â€ TST nâ—¦ 26: 110â€“27.
[11] Brenzel, Logan, and Pierre Claquin. 1994. â€œImmunization Programs and Their Costs.â€
     Social Science & Medicine 39 (4): 527â€“36. doi:10.1016/0277-9536(94)90095-7.
[12] Conybeare, John. 1948. â€œThe Effects on Mortality of Recent Advances in Treatment.â€
     Journal of the Institute of Actuaries 74: 57â€“81.
[13] Cosmacini, Giorgio, 2005. â€œStoria della medicina e della sanitaÌ€ in Italia.â€ Roma: Lat-
     erza.
[14] Croce, Benedetto. 1928. â€œStoria dâ€™Italia dal 1871 al 1915.â€ Bari: Laterza.
[15] Davis, Kingsley. 1956. â€œThe Amazing Decline of Mortality in Underdeveloped Areas.â€
     American Economic Review 46 (2): 305â€“18.
[16] Deaton, A. 2006. The Great Escape: A Review Essay on Fogelâ€™s The Escape from
     Hunger and Premature Death 1700-2100. Journal of Economic Literature 44 (1): 106-
     114.

                                              20
[17] Doria, Miguel de FrancÌ§a. 2010. â€œFactors Influencing Public Perception of Drinking Water
     Quality.â€ Water policy 12 (1): 1â€“19.

[18] Dowling, Harry. 1977. Fighting Infection: Conquests of the Twentieth Century. Cam-
     bridge: Harvard University Press.

[19] Easterlin, Richard. 1999. â€œHow Beneficent Is the Market? A Look at the Modern History
     of Mortality.â€ European Review of Economic History 3 (3): 257â€“94.

[20] Edwards, Ryan D., and Shripad Tuljapurkar. 2005. â€œInequality in Life Spans and a New
     Perspective on Mortality Convergence across Industrialized Countries.â€ Population and
     Development Review 31 (4): 645â€“674.

[21] Erdem, Hakan, Ahmet Tetik, Ozgur Arun, Bulent Ahmet Besirbellioglu, Omer Coskun,
     and Can Polat Eyigun. 2011. â€œWar and Infection in the Pre-Antibiotic Era: The Third
     Ottoman Army in 1915.â€ Scandinavian Journal of Infectious Diseases 43 (9): 690â€“95.
     doi:10.3109/00365548.2011.577801.

[22] Ermano, Paolo. 2012. â€œGli investimenti nel servizio idrico in Italia: unâ€™analisi storica.â€
     DIES Working Paper 3/2012.

[23] Ermano, Paolo, and Antonio Massarutto. 2012. â€œLâ€™acqua come bene economico: profili
     allocativi e distributivi.â€ Diritto Pubblico Comparato ed Europeo, 1-2012.

[24] Florey, M. E., and Howard W. Florey. 1943. â€œGeneral and Local Administration of
     Penicillin.â€ Lancet 1 (387).

[25] Fries, James F. 1980. â€œAging, Natural Death, and the Compression of Morbidity.â€ New
     England Journal of Medicine 303 (3): 130â€“5. doi:10.1056/NEJM198007173030304.

[26] Gillespie, Duncan O. S., Meredith V. Trotter, and Shripad D. Tuljapurkar. 2014. â€œDiver-
     gence in Age Patterns of Mortality Change Drives International Divergence in Lifespan
     Inequality.â€ Demography 51 (3): 1003â€“17. doi 10.1007/s13524-014-0287-8.

[27] Giovannini, Carla. 1996. â€œRisanare la cittaâ€˜. Lâ€™utopia igienista di fine Ottocento.â€ Angeli
     ed., Milano.

[28] Giuntini, Andrea. 1999. â€œGli ingegneri sanitari e lâ€™utopia igienista.â€ In Giuntini, A.,
     Minesso, M., Gli ingegneri in Italia tra 800 e 900, Milano, Franco Angeli, 117â€“128.

[29] Glei, Dana. 2015. â€œAbout Mortality Data for Italy.â€ Retrieved from http://www.
     mortality.org/hmd/ITA/InputDB/ITAcom.pdf (February 14, 2017)

[30] Golini A., Ciucci L., Caselli G. and Istat - Reparto studi sulla popolazione, 1983. Ri-
     costruzione della popolazione residente per sesso, et e regione. Anni 1952-1972â€. Uni-
     versit degli Studi di Roma â€œLa Spienzaâ€, Dipartimento di Scienze Demografiche, Fonti
     e strumenti, n.1.



                                              21
[31] Hemminki, Elina, and Anneli Paakkulainen. 1976. â€œThe Effect of Antibiotics on Mor-
     tality from Infectious Diseases in Sweden and Finland.â€ Am J Public Health. 66 (12):
     1180â€“4.

[32] HonoreÌ, Bo E., and Adriana Lleras-Muney. 2006. â€œBounds in Competing Risks Models
     and the War on Cancer.â€ Econometrica 74 (6): 1675â€“98.

[33] Human Mortality Database (HMD). University of California, Berkeley (USA), and Max
     Planck Institute for Demographic Research (Germany). Available at www.mortality.org
     or www.humanmortality.de (data downloaded on Jan 28th, 2017).

[34] ICD       (International      Classification           of        Diseases),         1948.
     http://www.wolfbane.com/icd/icd6h.htm

[35] ISTAT (National Institute of Statistics) 1956, Annuario di Statistiche Sanitarie (Volume
     II 1956).

[36] ISTAT (National Institute of Statistics) 1957a, Annuario di Statistiche Sanitarie (Vol-
     ume III, 1957).

[37] ISTAT (National Institute of Statistics) 1957b. â€œMorti e dispersi per cause belliche negli
     anni 1940â€“45.â€ Rome.

[38] ISTAT (National Institute of Statistics) 1958, Cause di morte 1888-1955, 1958, Roma.

[39] Janssen, Fanny, Anthe van den Hande, Joop de Beer, and Leo J. G. van Wissen. 2016.
     â€œSigma and Beta Convergence in Regional Mortality.â€ Demographic Research 35: 81â€“
     116.

[40] Jayachandran, Seema, Adriana Lleras-Muney, and Kimberly V. Smith. 2010. â€œModern
     Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of
     Sulfa Drugs.â€ American Economic Journal: Applied Economics 2 (2): 118â€“46.

[41] Jdanov, Dmitri A., Dana A. Glei, and Domantas Jasilionis. 2008. â€œA Modeling Approach
     for Estimating Total Mortality for Italy during the First and Second World Wars.â€
     Center for the Economics and Demography of Aging (CEDA) Papers: Paper 2008-
     0001CL.

[42] Kannisto, VaÌˆinoÌˆ. 2000. â€œMeasuring the Compression of Mortality.â€ Demographic Re-
     search 3. doi:10.4054/DemRes.2000.3.6.

[43] Kremer, Michael, and Jack Willis. 2016. â€œGuns, Latrines, and Land Reform: Private
     Expectations and Public Policy.â€ NBER Working Paper 21915.

[44] Levy, Stuart B. 1992. The Antibiotic Paradox: How Miracle Drugs Are Destroying the
     Miracle. New York: Plenum Press.

[45] Loudon, Irvine. 1988. â€œMaternal Mortality: 1800â€“1950. Some Regional and Interna-
     tional Comparisons.â€ Social History of Medicine 1: 183â€“228.

                                              22
[46] Luzzi Saverio. 2004. â€œSalute e sanitaÌ€ nellâ€™Italia Repubblicana.â€ Donzelli Editore, Roma.

[47] Mackenbach, Johan P., and Caspar W. Looman. 1988. â€œSecular Trends of Infectious
     Disease Mortality in the Netherlands, 1911â€“1978: Quantitative Estimates of Changes
     Coinciding with the Introduction of Antibiotics.â€ International Journal of Epidemiology
     17 (3): 618â€“624.

[48] Mandell Gerald, John Douglas and Raphael Bennett, 2010 Principles and Practices of
     Infectious Disease Routledge Press : Philadelphia, PA.

[49] Mantelli, Francesco, and Giorgio Temporelli. 2007. â€œLâ€™acqua nella storia.â€ Milano,
     Franco Angeli.

[50] Massarutto, Antonio. 2011. â€œPrivati dellâ€™acqua.â€ Bologna, Il Mulino.

[51] Mokyr, Joel. 2002. â€œInnovation in an Historical Perspective: Tales of Technology and
     Evolution.â€ In Technological Innovation and Economic Performance, edited by Benn
     Steil, David G. Victor, and Richard R. Nelson, 23â€“46. Princeton: Princeton University
     Press.

[52] Mosca, Gaetano. 1939. The Ruling Class. New York: McGraw-Hill.

[53] Olson, Mancur C. 1965. The Logic of Collective Action; Public Goods and the Theory
     of Groups. Cambridge: Harvard University Press.

[54] Picci, Lucio. 2002. â€œLe opere pubbliche dallâ€™unitaÌ dâ€™Italia: lâ€™informazione statistica.â€
     Rivista di Politica Economica.

[55] Pogliano, Claudio. 1984. â€œScienza e stirpe: eugenica in Italia 1912-1939.â€ Passato e
     Presente 5, Rivista di storia contemporanea: 61â€“97.

[56] Ponnapalli, Ramani, Krishna M. Ponnapalli, and A. Subbiah. 2013. â€œAging and the
     Demographic Transition in India and Its States: A Comparative Perspective.â€ Interna-
     tional Journal of Asian Social Science 3 (1): 171â€“193.

[57] Peterson, A. V. 1976. â€œBounds for a joint distribution function with fixed sub-
     distribution functions: Application to competing risks.â€ Proceedings of the National
     Academy of Sciences 73(1), 11-13.

[58] Preston, Samuel H. 1975. â€œThe Changing Relation between Mortality and Level of
     Economic Development.â€ Population Studies 29 (2): 231â€“248.

[59] Ratcliff, J.D. 1945. â€œYellow Magic: The Story of Penicillin. Random Houseâ€.

[60] Stephens, M. A. 1974. â€œEDF Statistics for Goodness of Fit and Some Comparisons.â€
     Journal of the American Statistical Association 69 (347): 730â€“737. doi:10.2307/2286009.

[61] Tsiatis, A. 1975. â€œA nonidentifiability aspect of the problem of competing risks.â€ Pro-
     ceedings of the National Academy of Sciences, 72(1), 20-22.


                                             23
[62] Tomes, Nancy. 1990. â€œThe Private Side of Public Health: Sanitary Science, Domestic
     Hygiene, and the Germ Theory, 1870â€“1900.â€ Bulletin of the History of Medicine LXIV:
     509â€“539.

[63] Tomes, Nancy. 1998. The Gospel of Germs: Men, Women, and the Microbe in American
     Life. Cambridge: Harvard University Press.

[64] Troesken, Werner. 2004. Water, Race, and Disease. Cambridge: MIT Press.

[65] Vecchi Giovanni. 2017. Measuring Wellbeing. A History of Italian Living Standards.
     Oxford: Oxford University Press.

[66] Vercelli, Marina, Roberto Lillini, Alberto Quaglia, Rosanna T. Micale, Sebastiano La
     Maestra, and Silvio De Flora. 2014. â€œAge-Related Mortality Trends in Italy from 1901
     to 2008.â€ PLoS ONE 9 (12). doi:10.1371/journal.pone.0114027.

[67] Wilmoth, John R., and Shiro Horiuchi. 1999. â€œRectangularization Revisited: Variability
     of Age at Death within Human Populations.â€ Demography 36 (4): 475â€“495. https:
     //doi.org/10.2307/2648085.

[68] Young, Andrew T., Matthew J. Higgins, and Daniel Levy. 2008. Sigma Convergence
     versus Beta Convergence: Evidence from U.S. County-Level Data. Journal of Money,
     Credit and Banking 40 (5): 1083â€“1093.

[69] Zapor, Michael J., and Kimberly A. Moran. 2005. â€œInfectious Diseases during Wartime.â€
     Current Opinion in Internal Medicine 4 (6): 543â€“47.




                                            24
Figure 1: All-cause mortality rates across all regions in Italy, 1924-1955. The unit is number
of deaths per 1,000 people. Source: ISTAT




                                             25
Figure 2: Penicillin-sensitive (Panel A) and penicillin-insensitive (Panel B) disease mortality
rates by region in Italy, 1924-1955. The unit is number of deaths per 1,000 people. Source:
ISTAT




                                              26
Figure 3: Period life-table distributions of age at death in Italy for selected years between
1924 and 1955. The unit is the logarithm of the probability density of deaths. Source:
Human Mortality Database (HMD)




                                             27
Figure 4: Life expectancy at birth and standard deviation of age at death in Italy, 1924â€“
1955. The trajectories of the life expectancy at birth (left-hand side scale), and the standard
deviation of age at death (right-hand side scale)are based on the distributions of age at death
from Fig. 3.




                                              28
Figure 5: Standard deviation (SD) of all-cause, penicillin-sensitive, and penicillin-insensitive
disease mortality in Italy, 1924â€“1955. The figure shows absolute levels of the SD by age
grouped in approximately 5-year bins. For the decade of 1940, we consider two age groups
using 1947 as a cut off to illustrate the effect of the introduction of penicillin in that year.




                                              29
Figure 6: Penicillin-sensitive disease regression coefficients by year (log mortality), 1924â€“
1955. The figure shows regression coefficients for penicillin-sensitive diseases by year, pre-
1947 and post-1947. The outcome is log mortality per 1,000. Regression included year and
region fixed effects, disease fixed effects, region-disease specific trends, and an interpolated
population estimate for age bins 0â€“25, 26â€“30, 31â€“35, 36â€“40, 41â€“45, 46â€“50, 51â€“55, 56â€“60,
61â€“65, 66â€“70, 71â€“75, 76+. Standard errors are clustered by region.




                                              30
Figure 7: Kolmogorov-Smirnov (KS) test of the equality of age at death mortality distribu-
tions in Italy, 1924â€“1958. The figure illustrates the significance level (p-value) of the KS test
for the equality of mortality distributions depicted in Fig. 3, using the distribution of 1955
as the baseline.




                                               31
   Table 1 Descriptive statistics comparing cause-specific mortality before and after 1947
                                    Descriptive Statistics
                                         1924â€“1946
 VARIABLES                                                   N           Mean          SD

 Penicillin-Sensitive Cause-Specific Mortality (per
                                                                       3,726         0.469         0.652
 1,000)
 Penicillin-InsensitiveCause-Specific Mortality (per
                                                                      11,093         0.237         0.510
 1,000)

                                                1947â€“1955
 VARIABLES                                                               N           Mean            SD
 Penicillin-Sensitive Cause-Specific Mortality (per
                                                                       1,457         0.189         0.265
 1,000)
 Penicillin-Insensitive Cause-Specific Mortality (per
                                                                       4,622         0.217         0.518
 1,000)

Note: The table reports descriptive statistics on the penicillin-sensitive and -insensitive specific mortality
from 1924â€“1946 and 1947â€“1955. Cause-specific mortality is the number of deaths per 1,000 people.
Source: ISTAT.




                                                     32
      Table 2 Baseline regressions of cause-specific mortality in Italy by regions, 1924â€“1955
                                Cause-Specific Mortality per          Log Cause-Specific Mortality
 Outcome
                                            1,000                               per 1,000

                                          (1)                 (2)                (3)                (4)
 Sensitive*Post                       -0.272***            -0.272***         -0.611***          -0.610***
                                       (0.008)              (0.008)           (0.023)            (0.023)

 Block Bootstrap SE                    (0.008)             (0.008)            (0.022)            (0.023)
 Block Bootstrap p-value               {0.002}             {0.002}            {0.002}            {0.002}

 Observations                           20,898              20,898             20,892             20,892
 R-squared                               0.867               0.868              0.887              0.887
 Year FE                                  Yes                 Yes                Yes                Yes
 Region FE                                Yes                 Yes                Yes                Yes
 Disease FE                               Yes                 Yes                Yes                Yes
 Region Trends                            No                  Yes                No                 Yes
 No. Clusters                             18                  18                 18                 18

Note: The table presents coefficient estimates for the regressions of cause-specific mortality per 1,000 on a
dummy variable for disease specific penicillin-sensitivity equal to 1 starting from 1947. In columns (1) and
(2) cause-specific mortality per 1,000 is in levels. In columns (3) and (4) cause-specific mortality is in logs.
All columns include year, region, disease fixed effects (FE), and interpolated population estimates for age
bins 0â€“25, 26â€“30, 31â€“35, 36â€“40, 41â€“45, 46â€“50, 51â€“55, 56â€“60, 61â€“65, 66â€“70, 71â€“75, 76+. Columns (2) and
(4) additionally include region-specific trends. Standard errors (SE) in parentheses are clustered by region.
Block bootstrap p-values are indicated in curly brackets




                                                      33
                     Table 3 Regression results by median of pre-1947 characteristics in Italy, 1924â€“1955
                                                                                Sensitivity to WWII Mortality
                                                                                                 Approach 2: Same as Columns
                                                            Approach 1: Varying Degrees of      (1) and (2), but Excluding Years
                                                               War-Related Destruction                Between 1943â€“1945
                             Above the                                                          Above the
                                            Below the
                             Median of                                                          Median of      Below the Median
                                          Median of All-
         Sample              All-Cause                                         Regions with     All-Cause      of All-Cause Pre-
                                            Cause Pre-
                             Pre-1947                       Regions with          Low           Pre-1947         1947 Mortality
                                          1947 Mortality
                             Mortality                     High Destruction    Destruction      Mortality
                                 (1)            (2)              (3)               (4)              (5)               (6)
 Sensitive*Post              -0.287***      -0.257***         -0.257***         -0.287***       -0.303***         -0.271***
                               (0.012)       (0.011)            (0.011)          (0.012)          (0.012)           (0.012)

 Block Bootstrap SE           (0.011)         (0.010)          (0.010)           (0.012)         (0.012)           (0.011)
 Block Bootstrap p-value      {0.002}         {0.004}          {0.004}           {0.002}         {0.004}           {0.002}

 Observations                 10,484          10,414            10,414            10,484          9,460             9,408
 R-squared                     0.875           0.901             0.899             0.873          0.873             0.899
 Year FE                        Yes             Yes               Yes               Yes            Yes               Yes
 Region FE                      Yes             Yes               Yes               Yes            Yes               Yes
 Disease FE                     Yes             Yes               Yes               Yes            Yes               Yes
 Region by Year FE              Yes             Yes               Yes               Yes            Yes               Yes
 Region Trends                  Yes             Yes               Yes               Yes            Yes               Yes


Note: The table presents coefficient estimates for the regressions of cause-specific mortality per 1,000 on
an indicator variable for disease specific penicillin-sensitivity after year 1947 in comparison to the pre-1947
regional mortality (columns 1-2), and in regions with high and low WWII destruction above the median
(columns 3-4). High and low cutoffs are determined respectively by being above and below the median of
the given sub sample mortality. Columns 5 and 6 present coefficient estimates for the regressions of annual
change of cause-specific mortality per 1,000 on the region-cause specific mortality at a baseline year, based
on the first sub-period (1924â€“1946) and for the second sub-period (1947â€“1955), respectively. The baseline
year is 1924 for the first sub-period, while it is 1947 for the second sub-period. The values in parentheses
represent robust standard errors (SE). We test the statistical significance of the difference between the
coefficient estimates from columns (1) vs. (2), (3) vs. (4), and (5) vs. (6) by pooling the samples from the
corresponding models and looking at the significance level of the estimate of a triple interaction term, that we
construct using the indicator variables for disease specific penicillin-sensitivity, post-47 level of mortality, and
the corresponding characteristic [e.g., for columns (1) and (2), the interaction term using the pooled sample
is Sensitive*Post*(High Penicillin-Sensitive Mortality)]. Cause-specific mortality per 1,000 is in levels. All
columns include year, region, disease fixed effects, region-specific trends, and an interpolated population
estimate for age bins 0â€“25, 26â€“30, 31â€“35, 36â€“40, 41â€“45, 46â€“50, 51â€“55, 56â€“60, 61â€“65, 66â€“70, 71â€“75, 76+.
Standard errors in parentheses are clustered by region. Block bootstrap p-values are indicated in curly
brackets.




                                                               34
      Table 4 Regression results for Î²-convergence by high vs. low penicillin-sensitive mortality
                      Pre Penicillin Period (1924â€“1946)         Post Penicillin Period (1947â€“1955)
      Sample         High Penicillin-     Low Penicillin-     High Penicillin-       Low Penicillin-
                        Sensitive             Sensitive           Sensitive        Sensitive Mortality
                        Mortality            Mortality           Mortality
                            (1)                  (2)                 (3)                   (4)
 Baseline                  -0.021***               -0.002              -0.075***              0.009***
 mortality (1924
 or 1947)
                             (0.001)               (0.002)              (0.002)                (0.002)

 Observations                 162                   424                   161                    508
 R-squared                   0.913                 0.059                 0.936                  0.149
 Region FE                    Yes                   Yes                   Yes                    Yes

Note:The table presents coefficient estimates for the regressions of annual change of cause-specific mortality
per 1,000 on the region-cause specific mortality at a baseline year. Columns 1 and 2 show results for the first
sub-period (1924â€“1946), and columns 3 and 4 for the second sub-period (1947â€“1955). The baseline year is
1924 for the first sub-period, while it is 1947 for the second sub-period. The values in parentheses represent
robust standard errors.




                                                      35
     Table 5 Effect of Penicillin on the Standard Deviation of Mortality Rates and Level of Mortality for Penicillin-Sensitive and -Insensitive Diseases
                        Outcome                          Standard Deviation (Sigma-convergence)                        Mortality Rate
              Category                                     Sensitive             Insensitive               Sensitive                 Insensitive
                                                              (1)                    (2)                      (3)                        (4)
      Post (Full Sample â€“end 1955)                          -0.113***                 -0.004                   -0.600***                  -0.340***
                                                              (0.014)                 (0.009)                   (0.075)                    (0.095)

      Post (Truncated Sample â€“end 1950)                     -0.090***                 -0.009                   -0.486***                  -0.363***
                                                              (0.014)                 (0.009)                   (0.075)                     (0.097)
36




      Difference in Post Coefficients (1955-1950)             -0.023                    0.005                    -0.114                      0.023


     Note: OLS regressions collapsed across deaths within region-years on an indicator for post introduction of Penicillin, region fixed effects, population in
     various age categories and linear time trends. The outcome in columns (1) and (2) is the standard deviation in mortality for sensitive and insensitive
     diseases, respectively. The outcome in columns (3) and (4) is the level of mortality from sensitive and insensitive diseases, respectively. Each cell
     in rows (1) and (2) reports the coefficient on the post indicator. The sample varies by row, extending over the entire analytical time period in row
     (1) and truncating in 1950 in row (2). Row (3) reports the difference between the full and truncated sample values. If competing risks are driving
     the results, the effects in row (2) should be considerably less negative in row (1), columns (2) and (4), due to individuals in the lowest part of the
     health distribution surviving infectious disease due to the introduction of Penicillin but dying at higher rates a few years later from non-communicable
     mortality.
                                         Appendix A

A.1 - The data-set on Causes of Death in Italy (1924-1955)
     In Italy data on mortality are collected routinely by the Italian National Statistical Office
(ISTAT) since 1888 and are published in the Health Statistics Yearbooks (Annuari di Statis-
tiche Sanitarie). As disease classifications have changed over time, we can identify 5 time
intervals, based on 5 different classifications: 1888-1955, 1956-1957, 1958-1967, 1968-1969
and after 1969. For our study we focus on the 1888-1955 period, although for convenience
we use the classification adopted in 1956-1957 as our reference classification (it presents
the less disaggregated set of information: 17 main causes of death and 99 more specific
pathologies) and, therefore, we have re-organized the 1888-1955 classifications to reflect the
1956-1957 classification.
     Originally, data for the period 1888-1955 were available only on paper in a single docu-
ment printed by ISTAT (ISTAT, 1958) and presented in form of time series by region and
cause of death. For our purposes all tables have been scanned and saved in form of excel
files. These row data have been further processed and double-checked in order to avoid
errors from the scanning process. During the 1888-1955 period the classification follows the
International Analytical Classification (IAC) code, which was approved in 1948 (ICD, 1948)
and adopted in Italy from 1951. The reconstruction of the time series before year 1951 has
been carried out by ISTAT. The classification adopted in 1956 and 1957 has changed from
the IAC to the ISTAT Intermediate Classification (IIC) coding system. Table A.1 provides
a detailed list of all diseases with the relative IIC code, while Table A.2 provides a link
between the IIC and the IAC coding system.
     The first column provides a brief description of the 17 main causes of death; the second
column reports the ISTAT classification used to identify causes (ranging from I to XVII)
and pathologies (ranging from 1 to 99); the third column describes the identification code
that we implemented starting from the ISTAT classification. It consists of 7 digits: the first
3 digits denote 1 out of the 17 causes of death (101 to 117); the following 2 digits denote 1
out of the 99 pathologies (from 01 to 99). The final 2 digits range from 00 to 10: they equal
zero for any of the 99 pathologies resulting from the 1956-1957 classification, and take on
different values (from 01 to 10) for further disaggregation of pathologies possibly occurred
either between years 1888-1955. In terms of regional disaggregation it is worth mentioning
that until 1923 data refers to the Italian partition of territories prior to the WWI; from 1924
to 1942, data are referred to the borders established after WWI; from 1943 onward, to the
borders after the WWII. Data prior to 1943 are referred, for each region, to the partition of
territories adopted at that time. Thus, the comparability across territories is imperfect for
those regions that have experienced border changes from 1927 (i.e., Veneto, Friuli-Venezia
Giulia, Umbria, Lazio, Abruzzi, Molise and Campania). To account for these geograph-
ical border changes and in order to have an harmonized regional disaggregation, we have
grouped together Abruzzi and Molise and Piedmont and Valle dAosta, that leads to have the
dataset disaggregated in the following 18 regions: Piedmont and Valle dAosta, Lombardy,
Trentino Alto Adige, Veneto, Friuli Venezia Giulia, Liguria, Emilia Romagna, Tuscany, Um-
bria, Marche, Lazio, Abruzzi and Molise, Campania, Apulia, Basilicata, Calabria, Sicily and
Sardinia.


                                               37
A.2 - Construction of mortality rates
     Mortality rates are obtained dividing number of deaths by resident population. Unfor-
tunately, data on resident population by region is available only starting from 1922 and is
obtained through a reconstruction made by Golini, Ciucci, Caselli and ISTAT (1983). As
it is only from 1924 that Italy was organized in 18 administrative regions (with only minor
changes with small borderline municipalities changing regions after that date) we decided to
start our analysis starts in 1924. For all these reasons we limit our analysis from 1924 to 1955.




                                               38
39
40
                                                                                                      Appendix B




Tab. B1 - LIST OF PENNICILIN SENSITIVE CAUSE OF DEATH
       FLAG                                            TOTAL DEATH BY 17 MAIN CAUSES
        1 antib.
        2 no antib.
        3 uncertain                                                                                                               YEARS AVAILABLE

FLAG       CODE            10         14          26   DESCRIPTION                                                              FROM     UNTIL
       1    1010000   101,000   1010,000   10100,000   infective and parasitic diseases (total)                                     1887     1969
       1    1010001   101,000   1010,001   10100,010   infective and parasitic diseases (females)                                   1958     1969
       1    1010010   101,001   1010,010   10100,100   infective and parasitic diseases (males)                                     1958     1969   Tubercolosys
       1    1010100   101,010   1010,100   10101,000   tubercolosis of respiratory system                                           1956     1969   Syphilis and its consequences
       1    1010101   101,010   1010,101   10101,010   all forms of tubercolosis                                                    1887     1955   Typhoid and paratyphoid fevers
       1    1010102   101,010   1010,102   10101,020   pulmonary tubercolosis                                                       1958     1967   Meningitis
       1    1010103   101,010   1010,103   10101,030   pleural tubercolosis                                                         1958     1967   Pneumonia
       1    1010104   101,010   1010,104   10101,040   adenopatia tubercolosis, tracheo-bronch. with symptoms                       1958     1967   Bronchitis
       1    1010105   101,011   1010,105   10101,050   other tubercolosis of respiratory system                                     1958     1967   Appendicitis
       1    1010200   101,020   1010,200   10102,000   other types of tubercolosis (total)                                          1956     1969   Peritonitis
       1    1010201   101,020   1010,201   10102,010   tbc of meningis and central nervous system                                   1958     1967   Nephritis and nephrosis.
       1    1010202   101,020   1010,202   10102,020   intestinal tbc, peritoneal and mesenteric glands                             1958     1967
       1    1010203   101,020   1010,203   10102,030   tbc of the bones                                                             1958     1967
       1    1010204   101,020   1010,204   10102,040   tbc linfatic system                                                          1958     1967
       1    1010205   101,021   1010,205   10102,050   tbc genitourinary system                                                     1958     1967
       1    1010206   101,021   1010,206   10102,060   other types of tubercolosis (residual)                                       1958     1967
       1    1010300   101,030   1010,300   10103,000   syphilis and consequences                                                    1887     1969
       1    1010301   101,030   1010,301   10103,010   syphilis of central nervous system                                           1958     1967
       1    1010302   101,030   1010,302   10103,020   other types of syphilis and its consequences                                 1958     1967
       1    1010400   101,040   1010,400   10104,000   typhoid and paratyphoid fevers                                               1887     1969
       1    1010401   101,040   1010,401   10104,010   typhoid fevers                                                               1958     1967
       1    1010402   101,040   1010,402   10104,020   paratyphoid fevers                                                           1958     1967
       1    1011001   101,100   1011,001   10110,010   gonococcic infections                                                        1958     1967
       1    1011002   101,100   1011,002   10110,020   other venereal diseases                                                      1958     1967
       1    1011003   101,100   1011,003   10110,030   brucellosis                                                                  1958     1967
       1    1011004   101,100   1011,004   10110,040   alimentary infections                                                        1958     1967
       1    1011005   101,101   1011,005   10110,050   scarlat fever                                                                1958     1967
       1    1011006   101,101   1011,006   10110,060   septicemia and piemia                                                        1958     1967
       1    1064001   106,400   1064,001   10640,010   meningithis                                                                  1887     1967
       1    1064401   106,440   1064,401   10644,010   keratitis                                                                    1959     1967
       1    1064402   106,440   1064,402   10644,020   inflammations of lacrimal glands and tear duct                               1958     1967
       1    1064403   106,440   1064,403   10644,030   other inflammatory eye diseases                                              1958     1967
       1    1064404   106,440   1064,404   10644,040   corneal ulcer                                                                1958     1967
       1    1064501   106,450   1064,501   10645,010   mastoiditis and otitis media                                                 1958     1967
       1    1074602   107,460   1074,602   10746,020   acute articular rheumatism with cardiac complications                        1958     1967
       1    1074701   107,470   1074,701   10747,010   mitral valve diseases, rheumatic and non specified diseases                  1958     1967
       1    1075201   107,520   1075,201   10752,010   endocarditis, myocarditis, and acute and subacute pericarditis               1958     1967
       1    1085700   108,570   1085,700   10857,000   pneumonia                                                                    1887     1969
       1    1085701   108,570   1085,701   10857,010   acute tonsillitis                                                            1958     1967
       1    1085702   108,570   1085,702   10857,020   other acute infections of upper respiratory tract                            1958     1967
       1    1085706   108,571   1085,706   10857,060   lobar pneumonia                                                              1958     1967
       1    1085707   108,571   1085,707   10857,070   other pneumonias                                                             1958     1967
       1    1085708   108,571   1085,708   10857,080   acute infections of respiratory tract, influenza and pneumonia               1958     1967
       1    1085800   108,580   1085,800   10858,000   bronchopneumonia                                                             1956     1969
       1    1085900   108,590   1085,900   10859,000   bronchitis                                                                   1887     1969
       1    1085901   108,590   1085,901   10859,010   acute and subacute bronchitis and not-specified bronchitis                   1958     1967
       1    1086001   108,600   1086,001   10860,010   other diseases and infections of upper respiratory tract                     1958     1967
       1    1086003   108,600   1086,003   10860,030   tonsils abscess                                                              1958     1967
       1    1086009   108,601   1086,009   10860,090   lung abscess                                                                 1958     1967
       1    1096200   109,620   1096,200   10962,000   appendicitis                                                                 1924     1969
       1    1096201   109,620   1096,201   10962,010   acute appendicitis                                                           1958     1967
       1    1096202   109,620   1096,202   10962,020   other types of appendicitis                                                  1958     1967
       1    1097004   109,700   1097,004   10970,040   peritonitis                                                                  1887     1967
       1    1107100   110,710   1107,100   11071,000   nephritis and nephrosis                                                      1887     1969
       1    1107101   110,710   1107,101   11071,010   acute nephritis                                                              1958     1967
       1    1107102   110,710   1107,102   11071,020   other nephritis or nephrosis                                                 1958     1967
       1    1107103   110,710   1107,103   11071,030   hydronephrosis and pyelorenal infections                                     1958     1967
       1    1107104   110,710   1107,104   11071,040   pyelorenal infections                                                        1958     1967
       1    1107302   110,730   1107,302   11073,020   cistitis                                                                     1958     1967
       1    1107502   110,750   1107,502   11075,020   orchitis and epididymitis                                                    1958     1967
       1    1107602   110,760   1107,602   11076,020   salpingitis and oophoritis                                                   1958     1967
       1    1107604   110,760   1107,604   11076,040   infective diseases of uterus, vagina, and vulva                              1958     1967
       1    1117701   111,770   1117,701   11177,010   infections of genito urinary system during pregnancy                         1958     1967
       1    1117702   111,770   1117,702   11177,020   pregnancy toxemia                                                            1958     1967
       1    1117802   111,780   1117,802   11178,020   abortion with infection                                                      1958     1967
       1    1128101   112,810   1128,101   11281,010   furunculus, anthrax and other abscesses                                      1958     1967
       1    1128102   112,810   1128,102   11281,020   other skin and cellulat tissue infections                                    1958     1967
       1    1138202   113,820   1138,202   11382,020   rheumatoid arthritis and similar diseases                                    1958     1967
       1    1138300   113,830   1138,300   11383,000   osteomyelitis and periostitis                                                1956     1969
       1    1158800   115,880   1158,800   11588,000   infections of newborns                                                       1956     1957
       2    1010500                                    difterite                                                                    1887     1969
       2    1010600                                    pertosse                                                                     1887     1969
       2    1010700                                    tetanus                                                                      1887     1969
       2    1010800                                    acute anterior poliomyelitis and its postums                                 1899     1969
       2    1010801                                    poliomyelitis                                                                1958     1967
       2    1010802                                    postums of acute anterior poliomyelitis                                      1958     1967
       2    1010900                                    morbillus                                                                    1887     1969
       2    1011007                                    parotite epidemica                                                           1958     1967
       2    1020000                                    tumors (total)                                                               1887     1969
       2    1020001                                    tumors (females)                                                             1958     1969
       2    1020010                                    tumors (males)                                                               1958     1969
       2    1021100                                    cancers of mouth and throat                                                  1956     1969
       2    1021101                                    all malignant tumors                                                         1887     1955
       2    1021102                                    cancers of lips                                                              1958     1967
       2    1021103                                    cancers of tongue                                                            1958     1967
       2    1021105                                    other cancers of mouth and throat                                            1958     1967
       2    1021200                                    cancers stomach                                                              1956     1969
       2    1021201                                    cancers esophagus                                                            1958     1967
       2    1021300                                    intestinal cancers                                                           1956     1969
       2    1021301                                    intestinal cancers and duodenal cancers                                      1958     1967
       2    1021302                                    rectal cancers                                                               1958     1967
       2    1021400                                    cancers biliary tract and liver                                              1956     1969
       2    1021500                                    other cancers digestive system                                               1956     1969
       2    1021600                                    laryngeal cancers, cancers of trachea, bronchial tubes, and lungs            1956     1969
       2    1021601                                    laryngeal cancers                                                            1958     1967
       2    1021602                                    cancers of trachea, bronchial tubes, and lungs                               1958     1967
       2    1021700                                    other cancers of respiratory system                                          1956     1969
       2    1021800                                    breast cancers                                                               1956     1969
       2    1021802                                    cancers of female genital organs                                             1958     1967
       2    1021900                                    cervical uterus cancers                                                      1956     1969
       2    1021901                                    cancers of other parts of uterus                                             1958     1967
       2    1022000                                    cancers of other female genital organs                                       1956     1969
       2    1022100                                    prostate cancers                                                             1956     1969
       2    1022101                                    other cancers of male genital organs                                         1958     1967
       2    1022200                                    cancers of urinal organs                                                     1956     1967
       2    1022300                                    cancers of other areas                                                       1956     1969
       2    1022301                                    hodgking disease                                                             1942     1967
       2    1022302                                    cancers of skin                                                              1958     1967
       2    1022303                                    cancers of brain and of other parts of nervous system                        1958     1967
       2    1022304                                    cancers of bones, cancers of connective and muscular tissue                  1958     1967
       2    1022305                                    other non-specified cancers                                                  1958     1967
       2    1022400                                    leukemia and aleukemia                                                       1931     1969
       2    1022500                                    others lymphoblastomas                                                       1956     1969
       2    1022600                                    all benign tumors                                                            1931     1969
       2    1022601                                    other benign tumors of non specific origins                                  1958     1967
       2    1022602                                    benign tumors of breast                                                      1958     1967




                                                                                                                           41
Tab. B1 - LIST OF PENNICILIN SENSITIVE CAUSE OF DEATH - Cntd
       FLAG                        TOTAL DEATH BY 17 MAIN CAUSES
        1 antib.
        2 no antib.
        3 uncertain                                                                                                             YEARS AVAILABLE

FLAG       CODE       10   14   26 DESCRIPTION                                                                                FROM     UNTIL
       2    1022603                benign tumors of uterus                                                                        1958     1967
       2    1022604                benign tumors of skin                                                                          1958     1967
       2    1022605                benign tumors of bones and cartilages                                                          1958     1967
       2    1022606                lipomas                                                                                        1958     1967
       2    1022607                other not specific benign tumors                                                               1958     1967
       2    1022608                tumors of not specified origins                                                                1933     1967
       2    1030000                allergic diseases, endocrine gland disorders, metabolic and nutrition diseases (total)         1887     1969
       2    1030001                allergic diseases, endocrine gland disorders, metabolic and nutrition diseases (females)       1958     1969
       2    1030010                allergic diseases, endocrine gland disorders, metabolic and nutrition diseases (males)         1958     1969
       2    1032700                allergic diseases                                                                              1924     1967
       2    1032701                asthma                                                                                         1958     1967
       2    1032702                other allergic diseases                                                                        1958     1967
       2    1032800                diseases of thyroid gland                                                                      1956     1969
       2    1032801                goitre                                                                                         1958     1967
       2    1032802                thyrotoxicosis                                                                                 1958     1967
       2    1032803                other diseases of thyroid gland                                                                1958     1967
       2    1032804                diseases of thyroid and paratyroid glands                                                      1887     1955
       2    1032900                diabetes                                                                                       1887     1969
       2    1033000                diseases of other endocrine glands                                                             1956     1969
       2    1033001                diseases of other endocrine glands and other methabolism diseases                              1887     1955
       2    1033100                vitamine deficiency and other metabolic diseases                                               1956     1969
       2    1040000                blood diseases and hematopoietic disorders (total)                                             1887     1969
       2    1040001                blood diseases and hematopoietic disorders (females)                                           1958     1969
       2    1040010                blood diseases and hematopoietic disorders (males)                                             1958     1969
       2    1043200                anaemias                                                                                       1956     1969
       2    1043201                pernicious anaemia and other hyperchromic anaemias                                             1924     1967
       2    1043202                hypocromic amaemias                                                                            1958     1967
       2    1043203                other anaemias                                                                                 1924     1967
       2    1050000                psychic disorders, psychoneurosis and personality disorders (total)                            1887     1969
       2    1050001                psychic disorders, psychoneurosis and personality disorders (females)                          1958     1969
       2    1050010                psychic disorders, psychoneurosis and personality disorders (males)                            1958     1969
       2    1053400                psychosis                                                                                      1956     1969
       2    1053401                schizophrenia (premature dementia)                                                             1958     1967
       2    1053402                manic depressive psychosis                                                                     1958     1967
       2    1053403                involutional melancholia                                                                       1958     1967
       2    1053404                paranoia and paranoid psychosis                                                                1958     1967
       2    1053405                senile psychosis                                                                               1958     1967
       2    1053406                alcoolic psychosis                                                                             1958     1967
       2    1053407                other psychosis                                                                                1958     1967
       2    1053500                psychoneurosis                                                                                 1956     1969
       2    1053501                anxiety states without somatic symptoms                                                        1958     1967
       2    1053502                hysterical reaction without anxiety state                                                      1958     1967
       2    1053503                neurodepressive reaction                                                                       1958     1967
       2    1053504                psychoneurosis with somatic symptoms                                                           1958     1967
       2    1053505                other psychic disorders                                                                        1958     1967
       2    1053600                psychic disorders of personality, intelligence, and behaviour                                  1956     1969
       2    1053601                alchoolism                                                                                     1958     1967
       2    1053602                oligophrenia                                                                                   1958     1967
       2    1053603                other psychic disorders of personality, intelligence, and behaviour                            1958     1967
       2    1060000                nervous system diseases and sensory organs diseases (total)                                    1887     1969
       2    1060001                nervous system diseases and sensory organs diseases (females)                                  1958     1969
       2    1060010                nervous system diseases and sensory organs diseases (males)                                    1958     1969
       2    1063700                hemorragia cerebral                                                                            1956     1969
       2    1063800                cerebral thrombosis and embolism                                                               1956     1969
       2    1063900                vascular lesions of central nervous system                                                     1887     1969
       2    1064000                inflammatory diseases of central nervous system                                                1956     1969
       2    1064002                other inflammatory diseases of central nervous system                                          1958     1967
       2    1064100                epilepsia                                                                                      1887     1969
       2    1064200                other non-inflammatory diseases of central nervous system (total)                              1956     1969
       2    1064201                cerebral paralysis                                                                             1931     1967
       2    1064202                other non-inflammatory diseases of central nervous system (residual)                           1958     1967
       2    1064300                diseases of peripheral nervous system                                                          1956     1967
       2    1064301                sciatica                                                                                       1958     1967
       2    1064302                other neuralgias and neuritis                                                                  1958     1967
       2    1064303                other diseases of peripheral nervous system                                                    1958     1967
       2    1064405                strabismus                                                                                     1963     1967
       2    1064406                cataract                                                                                       1958     1967
       2    1064407                retina detachment                                                                              1958     1967
       2    1064408                glaucoma                                                                                       1958     1967
       2    1064409                other non-inflammatory eye diseases                                                            1958     1967
       2    1064500                ear and mastoid apophysis diseases                                                             1956     1969
       2    1074600                acute articular rheumatism                                                                     1956     1969
       2    1074601                acute articular rheumatism without cardiac complications                                       1958     1967
       2    1074700                chronic rheumatic cardiopathies                                                                1956     1969
       2    1074702                other chronic rheumatic cardiopathies                                                          1958     1967
       2    1074800                heart atherosclerosis and coronary diseases                                                    1956     1969
       2    1074900                chronic non rheumatic endocarditis                                                             1956     1967
       2    1075000                degenerative myocardial atherosclerosis                                                        1956     1967
       2    1075100                other myocardial degenerations                                                                 1956     1969
       2    1075200                other heart diseases                                                                           1956     1969
       2    1075202                functional heart diseases                                                                      1958     1967
       2    1075203                other heart diseases                                                                           1958     1967
       2    1075300                hypertension with heart disease                                                                1956     1969
       2    1075301                benign hypertension with heart disease                                                         1958     1967
       2    1075302                other hypertensions with heart disease                                                         1958     1967
       2    1075400                hypertension without heart diseases                                                            1956     1967
       2    1075401                benign hypertension without heart disease                                                      1958     1967
       2    1075402                other hypertensions without heart disease                                                      1958     1967
       2    1075500                generalized atherosclerosis                                                                    1956     1969
       2    1075600                other diseases of arteries and vascular peripheral                                             1956     1969
       2    1075601                varicose veins lower limbs                                                                     1958     1967
       2    1075602                hemorrhoids                                                                                    1958     1967
       2    1075603                other varicose veins with specified localizations                                              1958     1967
       2    1075604                phlebitis and thrombophlebitis                                                                 1958     1967
       2    1075605                other veins diseases and circulatory system diseases                                           1958     1967
       2    1085703                influenza                                                                                      1887     1967
       2    1085704                influenza with bronchitis and bronchopneumonia                                                 1958     1967
       2    1085705                other types of influenza                                                                       1958     1967
       2    1086002                tonsils hypertrophy and adenoids                                                               1958     1967
       2    1086005                nasal septum deviation                                                                         1958     1967
       2    1086006                polyp nasal cavity                                                                             1958     1967
       2    1086010                pneumoconiosis                                                                                 1958     1967
       2    1086011                bronchiectasia                                                                                 1958     1967
       2    1096100                gastric, duodenal and digiunal ulcer                                                           1956     1969   Note: This was not treated with antibiotics during this period
       2    1096102                teeth diseases                                                                                 1958     1967
       2    1096104                stomach and duodenal ulcers and other diseases of stomach and duodenum                         1887     1955
       2    1096105                stomach ulcer                                                                                  1958     1967   Note: This was not treated with antibiotics during this period
       2    1096106                duodenal ulcer                                                                                 1958     1967   Note: This was not treated with antibiotics during this period
       2    1096107                gastro-digiunal ulcer                                                                          1958     1967
       2    1096108                gastritis, duodenitis and other diseases of stomach and duodenum                               1958     1967
       2    1096109                gastritis, duodenitis                                                                          1958     1967
       2    1096110                other diseases of stomach and duodenum                                                         1958     1967
       2    1096300                abdominal hernia                                                                               1956     1969
       2    1096301                abdominal hernia without mention of obstruction                                                1958     1967
       2    1096302                abdominal hernia with obstruction                                                              1887     1967
       2    1096400                intestinal obstruction without mention of hernia                                               1956     1969
       2    1096500                gastroenteritis, colitis, and non-ulcerative colitis 29th day to 3rd year                      1956     1957
       2    1096600                gastroenteritis from the 3rd year onwards and chronic colitis                                  1956     1967
       2    1096602                gastroenteritis, colitis and ulcerative colitis                                                1887     1955
       2    1096700                liver cirrhosis                                                                                1887     1969
       2    1096800                biliary lithiasis and cholecystitis                                                            1956     1969
       2    1096801                bladder diseases and biliary tract diseases                                                    1931     1955
       2    1097002                functional disorders of intestine                                                              1958     1967




                                                                                            42
Tab. B1 - LIST OF PENNICILIN SENSITIVE CAUSE OF DEATH - Cntd
       FLAG                        TOTAL DEATH BY 17 MAIN CAUSES
        1 antib.
        2 no antib.
        3 uncertain                                                                                         YEARS AVAILABLE

FLAG       CODE       10   14   26 DESCRIPTION                                                            FROM     UNTIL
       2    1097003                rhagades, anal and rectal abscess                                          1958     1967
       2    1097006                cholecystitis without mention of calculus                                  1958     1967
       2    1107200                calculus urinary system                                                    1924     1969
       2    1107400                prostatic hypertrophy and hyperplasia                                      1956     1969
       2    1107501                hydrocele                                                                  1958     1967
       2    1107605                genital prolapse                                                           1958     1967
       2    1107606                uterus deviations                                                          1958     1967
       2    1107608                menstrual disorders                                                        1958     1967
       2    1117703                placenta previa and hemorrhages in pregnancy                               1958     1967
       2    1117704                extra uterine pregnancy                                                    1958     1967
       2    1117801                abortion without infections, with or without toxemia                       1958     1967
       2    1118001                placenta previa and hemorrhage post-partum                                 1958     1967
       2    1118002                dystocia due to anomaly of bone pelvis                                     1958     1967
       2    1118003                dystocia due to anomaly of fetus                                           1958     1967
       2    1128103                eczema                                                                     1958     1967
       2    1138200                arthritis and rheumatism (except acute articular rheumatism                1956     1969
       2    1138201                acute arthritis                                                            1958     1967
       2    1138203                arthrosis and similar diseases                                             1958     1967
       2    1138204                other, not specified arthritis                                             1958     1967
       2    1138205                rheumatism (except acute articular rheumatism)                             1958     1967
       2    1138401                osteitis deformans and osteochondrosis and other bone diseases             1958     1967
       2    1140000                congenital malformations (total)                                           1887     1969
       2    1140001                congenital malformations (females)                                         1958     1969
       2    1140010                congenital malformations (males)                                           1958     1969
       2    1148500                congenital malformations of circulatory system                             1956     1969
       2    1148600                other congenital malformations                                             1956     1969
       2    1148601                congenital malformations of genitourinary system                           1958     1967
       2    1148602                congenital malformations of bones and articulations                        1958     1967
       2    1148603                remaining congenital malformations                                         1958     1967
       2    1158700                obstetrical disorder, asphyxia and newborn infections                      1956     1969
       2    1158900                nutrition disorders                                                        1956     1969
       2    1160000                symptoms, senility, and pathological states (total)                        1887     1969
       2    1160001                symptoms, senility, and pathological states (females)                      1958     1969
       2    1160010                symptoms, senility, and pathological states (males)                        1958     1969
       2    1169200                senility without mention of psychosis                                      1956     1969
       2    1169300                symptoms and causes mis-defined and unknown                                1956     1969
       2    1179702                accidental poisoning                                                       1958     1967
       2    1179800                suicides                                                                   1887     1969
       2    1179900                homicides                                                                  1887     1969
       2    1179901                suicides and homicides                                                     1959     1967
       3    1011000                other infectious and parasitic diseases                                    1887     1969
       3    1011008                other infectious diseases                                                  1958     1967
       3    1043300                other blood diseases and hematopoietic organs                              1887     1969
       3    1064400                eyes diseases                                                              1924     1969
       3    1064502                other ear and mastoid apophysis diseases                                   1958     1967
       3    1070000                circulatory system diseases (total)                                        1887     1969
       3    1070001                circulatory system diseases (females)                                      1958     1969
       3    1070010                circulatory system diseases (males)                                        1958     1969
       3    1080000                respiratory system diseases (total)                                        1887     1969
       3    1080001                respiratory system diseases (females)                                      1958     1969
       3    1080010                respiratory system diseases (males)                                        1958     1969
       3    1085902                chronic bronchitis                                                         1958     1967
       3    1086000                other diseases of respiratory tract                                        1956     1969
       3    1086004                chronic sinusitis                                                          1958     1967
       3    1086007                remaining diseases and chronic infections of upper respiratory tract       1958     1967
       3    1086008                pleurisy                                                                   1887     1967
       3    1086012                remaining diseases of respiratory tract                                    1958     1967
       3    1090000                digestive system diseases (total)                                          1887     1969
       3    1090001                digestive system diseases (females)                                        1958     1969
       3    1090010                digestive system diseases (males)                                          1958     1969
       3    1096101                diseases mouth cavity and esophagus                                        1958     1967
       3    1096103                other diseases mouth cavity and esophagus                                  1958     1967
       3    1096900                other diseases of liver, pancreas                                          1924     1969
       3    1097000                other diseases of digestive system                                         1956     1969
       3    1097001                other diseases of intestine and peritoneum                                 1958     1967
       3    1097005                remaining diseases of intestine and peritoneum                             1958     1967
       3    1100000                genitourinary system diseases (total)                                      1887     1969
       3    1100001                genitourinary system diseases (females)                                    1958     1969
       3    1100010                genitourinary system diseases (males)                                      1958     1969
       3    1107105                hydronephrosis                                                             1958     1967
       3    1107300                other diseases of urinary system                                           1956     1969
       3    1107301                other renal diseases and urethritis                                        1958     1967
       3    1107303                remaining diseases of urinary system                                       1958     1967
       3    1107500                other diseases of male genital organs                                      1956     1969
       3    1107503                remaining diseases of male genital organs                                  1958     1967
       3    1107600                breast diseases and disease of female genital organs                       1956     1969
       3    1107601                breast diseases                                                            1958     1967
       3    1107603                other diseases of female pelvic peritoneum                                 1958     1967
       3    1107607                other uterus diseases                                                      1958     1967
       3    1107609                other disorders female genital organs                                      1958     1967
       3    1110000                complications of pregnancy, childbirth, and the puerperium (total)         1887     1969
       3    1117700                pregnancy complications                                                    1956     1969
       3    1117705                other complications in pregnancy                                           1958     1967
       3    1117800                abortion                                                                   1956     1969
       3    1118000                complications of childbirth, and the puerperium                            1956     1969
       3    1118004                other complications of childbirth                                          1958     1967
       3    1118005                puerperium complications                                                   1958     1967
       3    1118006                breast-feeding disorders                                                   1958     1967
       3    1120000                skin and tissue diseases (total)                                           1887     1969
       3    1120001                skin and tissue diseases (females)                                         1958     1969
       3    1120010                skin and tissue diseases (males)                                           1958     1969
       3    1128104                erythematosus affections                                                   1958     1967
       3    1128105                psoriasis and similar disorders                                            1958     1967
       3    1128106                other skin and cellular tissue infections                                  1958     1967
       3    1130000                bone diseases and locomotive organ diseases (total)                        1887     1969
       3    1130001                bone diseases and locomotive organ diseases (females)                      1958     1969
       3    1130010                bone diseases and locomotive organ diseases (males)                        1958     1969
       3    1138400                other diseases of bones locomotive organs                                  1956     1969
       3    1138402                knee intra-articular disease                                               1958     1967
       3    1138403                intervertebral disc diseases                                               1958     1967
       3    1138404                other articular diseases                                                   1958     1967
       3    1138405                synovitis, bursitis and tenosynovitis                                      1958     1967
       3    1138406                remaining diseases of osteo-muscolar system                                1958     1967
       3    1150000                early childhood particular diseases (total)                                1887     1969
       3    1150001                early childhood particular diseases (females)                              1958     1969
       3    1150010                early childhood particular diseases (males)                                1958     1969
       3    1159000                immaturity                                                                 1956     1969
       3    1159100                other particular diseses of early childhood                                1956     1969
       3    1170000                accidents, traumatisms and poisonings (total)                              1887     1969
       3    1170001                accidents, traumatisms and poisonings (females)                            1958     1969
       3    1170010                accidents, traumatisms and poisonings (males)                              1958     1969
       3    1179400                accidents caused to pedestrian by motor vehicle                            1956     1969
       3    1179500                other accidents caused by motor vehicle                                    1956     1967
       3    1179501                traffic accidents                                                          1958     1967
       3    1179600                accidents caused by other motor vehicles                                   1956     1969
       3    1179602                accidents by transportation through waterways                              1958     1967
       3    1179603                aviation accidents                                                         1958     1967
       3    1179604                railway accidents                                                          1958     1967
       3    1179700                other accidents                                                            1887     1969
       3    1179703                accidental downfalls                                                       1958     1967
       3    1179704                accidents caused by fire-arms                                              1958     1967
       3    1179705                accidental drowning                                                        1958     1967
       3    1179706                other accidents                                                            1958     1967
       3    1179707                trauma war                                                                 1958     1967
            1180000                total deaths                                                               1887     1957




                                                                                              43
